$INGR

Ingredion (INGR) SVP, CIO now holds 1,866.963 phantom units

Ingredion Inc (INGR) reported that SVP, CIO Michael J. Leonard acquired 33.015 phantom stock units on August 31, 2026, under a Non-Qualified Deferred Compensation Plan. Each unit represents the right to receive one share of common stock. Leonard now holds 1,866.963 phantom units. The grant was valued at $3K based on the closing stock price of $103.46 per share.

Original reporting
Published Sep 1, 2026, 4:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 3:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$INGR
Neutral
high confidence
Mentioned
$INGR
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$INGRNeutralLow
01

Why it matters

The grant is a routine compensation award with negligible market impact.

02

Market read

Minor insider compensation filing; no expected price movement.

03

What to watch

Potential future dilution if phantom units are settled, but no immediate effect.

Relevance 4/10Novelty 4/10Timing: post‑transaction on Aug 31, 2026

Background

Ingredion Inc. filed a Form 4 showing a phantom stock grant to its SVP, CIO & Head of Prot. Fort.

Company-level read

Ticker impact

$INGRNeutralHigh confidence
Context

Form 4 disclosed Michael J. Leonard received 33.015 phantom stock units, raising his holdings to 1,866.963 units.

Expected impact

no material price change expected

Evidence & confidence

The grant is valued at roughly $3,000, a trivial amount for a mid‑cap company, and phantom units do not affect share count.

Market effects

none

none

none

Counterpoint

Even small insider grants can signal confidence, but the size here is too minor to matter.

Key entities

  • Michael J. Leonard

    SVP, CIO & Head of Prot. Fort. at Ingredion

  • Ingredion Inc.

    Food ingredients producer (ticker INGR)

Related articles

$INGRMed

Ingredion (INGR), Why Is It Back In The Spotlight?

Ingredion (INGR) appointed Diego Reynoso as CFO, effective October 1, 2026. The company's share price is $104.62, with mixed recent returns. Analysts have differing views on its valuation, with AgWiz estimating it as 18.6% overvalued at a fair value of $88.23, while another DCF model values it at $222.82. The company's future performance depends on its integration of Tate & Lyle and shift to specialty ingredients.

$INGRMedAI 8/10

Ingredion's carrot fibre wins EU approval

Ingredion received EU approval for Benicaros SF Pure P, a carrot fibre, allowing its sale in the EU from July 2026. The fibre is plant-based, low-dose, and designed for use in foods, beverages, and supplements without affecting taste or texture. Ingredion acquired Benicaros in June 2026, positioning the ingredient as part of its focus on science-backed nutrition. The EU approval could boost adoption among European formulators.

$DARMedAI 8/10

A Look Back at Ingredients, Flavors & Fragrances Stocks’ Q2 Earnings: Darling Ingredients (NYSE:DAR) Vs The Rest Of The Pack

Ingredients, flavors, and fragrances stocks reported mixed Q2 earnings, with revenues missing estimates by 2.4%. Darling Ingredients (DAR) reported $1.72B revenue, up 16.4% YoY, beating estimates. Archer-Daniels-Midland (ADM) reported $22.68B revenue, up 7.2% YoY, outperforming estimates. International Flavors & Fragrances (IFF) reported $1.95B revenue, down 29.3% YoY, missing estimates. Ingredion (INGR) reported $1.85B revenue, flat YoY, topping estimates. Bunge Global (BG) reported $24.04B rev

$INGRMedAI 8/10

Ingredion (INGR) Q2 2026 Earnings Call Transcript

Ingredion (NYSE:INGR) reported Q2 2026 net sales of $1.85B (+1%) and adjusted operating income of $258M (-5%). Adjusted EPS was $2.82. Management cited Argo facility issues, Mexico currency headwinds, and rising tapioca costs. It reaffirmed 2026 adjusted EPS guidance of $10.30 to $10.90 and expects Tate & Lyle acquisition synergies of $130M run-rate by 2030.